This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Carmine Therapeutics Pte. Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Waqas Muhammad Usman: Innovator in Extracellular Vesicle Technology
Introduction
Waqas Muhammad Usman is an accomplished inventor based in Hong Kong, CN, known for his significant contribution to the field of biotechnology. His innovative work is focused on the development of extracellular vesicle technology, which holds promise for various medical applications.
Latest Patents
Waqas Muhammad Usman has been granted a patent for his invention titled "Nucleic acid loaded extracellular vesicles." This patent describes an extracellular vesicle loaded with nucleic acid cargo and outlines a method for preparing the loaded vesicle. This breakthrough has the potential to enhance therapeutic delivery systems in medicine.
Career Highlights
Waqas currently works at Carmine Therapeutics Pte. Ltd., a company dedicated to advancing innovative therapeutic solutions. His role involves utilizing his expertise to further develop technologies that could lead to significant medical advancements.
Collaborations
Throughout his career, Waqas has collaborated with esteemed colleagues, including Harvey F. Lodish and Ronne Yeo. These collaborations have enriched his research and contributed to the successful development of his innovative solutions in the biotechnology sector.
Conclusion
Waqas Muhammad Usman stands out as a prominent inventor whose work in extracellular vesicle technology is paving the way for future innovations in biotechnology. His patent on nucleic acid loaded extracellular vesicles exemplifies the blend of creativity and scientific rigor that drives advancements in medical therapies. As he continues his work at Carmine Therapeutics Pte. Ltd., the impact of his contributions is expected to resonate within the industry for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile